Answer to Question 1
2
Rationale 1: Androgens will help with athletic performance, but this is not the reason the drug would be administered in a clinical setting.
Rationale 2: High doses of androgens are occasionally used as a palliative measure to treat certain types of breast cancer.
Rationale 3: Androgens would not have any effect on brain cancer.
Rationale 4: Sexual reassignment surgery would not be the reason for the drug to be administered in a clinical setting.
Global Rationale: High doses of androgens are occasionally used as a palliative measure to treat certain types of breast cancer. Androgens will help with athletic performance, but this is not the reason the drug would be administered in a clinical setting. Androgens would not have any effect on brain cancer. Sexual reassignment surgery would not be the reason for the drug to be administered in a clinical setting.
Answer to Question 2
2
Rationale 1: Beta blockers are not used to treat Alzheimer disease.
Rationale 2: Acetylcholinesteras e inhibitors are used to treat Alzheimer disease.
Rationale 3: Cholinergic blockers are used to treat Parkinson disease.
Rationale 4: Dopaminergic agents are used to treat Parkinson disease.
Global Rationale: Acetylcholinesteras e inhibitors are used to treat Alzheimer disease. The acetylcholinesteras e inhibitors indirectly stimulate the receptors for ACh. Beta blockers are not used to treat Alzheimer disease. Cholinergic blockers are used to treat Parkinson disease. Dopaminergic agents are used to treat Parkinson disease.